GlassScriptPhysician profile
Rene Quiroz
NPI 1164558540
$7,252.23
in general payments reported to CMS, 2019-2025
40 companies · $325 in 2025
The $325 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,131 · 2020: $780 · 2021: $1,489 · 2022: $1,229 · 2023: $1,436 · 2024: $863 · 2025: $325.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,623.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,623.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $1,211.28 | 2019-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $1,058.54 | 2019-2025 | |
| Medtronic, INC. | $808.88 | 2021-2023 | Corevalve Evolut R |
| Pfizer INC. | $710.50 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $510.20 | 2021-2025 | Verquvo |
| Boston Scientific Corporation | $415.15 | 2022-2025 | Watchman Flx, Cds - Mct/Cem Monitoring, Bodyguardian |
| Medtronic Vascular, INC. | $341.24 | 2019-2020 | |
| Ancora Heart, INC. | $237.75 | 2021-2023 | Accucinch |
| E.R. Squibb & Sons, L.L.C. | $230.04 | 2019-2025 | Camzyos, Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $227.42 | 2021-2025 | Jardiance |
| Abbott Laboratories | $170.27 | 2023 | Thoratec Heartmate 3 Lvas Implant Kit |
| Abiomed | $166.63 | 2021-2023 | Impella |
| Esperion Therapeutics, INC. | $141.98 | 2020-2021 | |
| Amgen INC. | $136.99 | 2019-2025 | Repatha, Repatha |
| Amarin Pharma, INC. | $134.59 | 2019-2022 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rene Quiroz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.